Par Hyare | Investor Relations |
Dayton Misfeldt | Interim Chief Executive Officer |
Judy Fox | Chief Scientific Officer, Executive Vice President, Research & Development |
Justin Kim | Oppenheimer |
Marc Frahm | Cowen |
Ladies and gentlemen, thank you for standing by and welcome to Quarter First 2020 Sunesis Pharmaceutical Incorporated Earnings Conference Call. At this time, all participants’ lines are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Mr.